Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practical examples: trials and conclusions -- an interactive segment.

N J Talley1

  • 1Mayo Clinic of Medicine and Division of Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA. talley.nicholas@mayo.edu

Alimentary Pharmacology & Therapeutics
|October 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Anxiety and Depression on the Interplay Between Disorders of Gut-Brain Interaction and Eating Disorders.

Clinical and translational gastroenterology·2026
Same author

Evidence for Brain-To-Gut and Gut-To-Brain Pathways in Primary Care Patients With Disorders of Gut-Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease.

Neurogastroenterology and motility·2025
Same author

Diabetes distress and depression are independently associated with gastrointestinal symptoms in type 2 diabetes in Bangladesh.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same author

Neonatal immune challenge influences the microbiota and behaviour in a sexually dimorphic manner.

Brain, behavior, and immunity·2022
Same author

Call for emergency action to limit global temperature increases, restore biodiversity and protect health.

BMJ military health·2021
Same author

Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trial.

Alimentary pharmacology & therapeutics·2021

Critical review of reflux disease management literature reveals common methodological flaws. Many studies overstate findings from small patient groups, impacting clinical practice adoption and requiring robust trial design for reliable evidence.

Area of Science:

  • Gastroenterology
  • Clinical Trial Methodology
  • Evidence-Based Medicine

Background:

  • Reflux disease management literature is frequently used to guide clinical practice.
  • A critical evaluation of this literature is necessary to ensure the validity of interventions adopted into everyday practice.
  • Concerns exist regarding the quality and interpretation of published studies in this field.

Purpose of the Study:

  • To critically review the literature on reflux disease management.
  • To identify common methodological weaknesses in published studies.
  • To assess the implications of these weaknesses for the adoption of interventions in clinical practice.

Main Methods:

  • Literature review and critical appraisal of published studies on reflux disease management.

Related Experiment Videos

  • Analysis of study design, statistical power, endpoint definition, and interpretation of results.
  • Identification of biases, such as publication bias and over-interpretation of small-sample studies.

    • Main Results:

    • Many published studies in reflux disease management exhibit methodological limitations.
    • Over-interpretation of positive findings from small patient cohorts is common, potentially influenced by publication bias.
    • Claims of treatment equivalence are often unsubstantiated due to inadequate study power and lack of pre-specified equivalence margins.
    • A frequent issue is the absence of pre-defined, clinically relevant primary endpoints.

    Conclusions:

    • The critical appraisal of reflux disease management literature highlights significant concerns about study validity.
    • Methodological weaknesses, including small sample sizes and undefined endpoints, can lead to unreliable conclusions.
    • Healthcare professionals must exercise caution when adopting interventions based on potentially flawed evidence.
    • Improved trial design and reporting standards are crucial for advancing reflux disease management.